Intestinal T-Cell Lymphoma — Trials

Intestinal T-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02561273	Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma	completed	Phase 1 / Phase 2	54	University of NebraskaOTHER	1	Dec 13, 2023	clinicaltrials
NCT03049449	T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas	completed	Phase 1	26	National Cancer Institute (NCI)NIH	1	Jan 18, 2023	clinicaltrials